|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 11/14/19 MediXall Group, Inc. 10-Q 9/30/19 41:1.8M Edgar Filing LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 301K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 21K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
33: R1 Document and Entity Information HTML 47K
14: R2 Condensed Consolidated Balance Sheets HTML 75K
23: R3 Condensed Consolidated Balance Sheets HTML 34K
(Parenthetical)
38: R4 Condensed Consolidated Statements of Operations HTML 50K
31: R5 Consolidated Statement of Changes in Stockholders' HTML 54K
Equity (Deficit)
13: R6 Consolidated Statement of Changes in Stockholders' HTML 17K
Equity (Deficit) (Parenthetical)
22: R7 Condensed Consolidated Statements of Cash Flows HTML 75K
37: R8 Organization and Nature of Operations HTML 18K
34: R9 Going Concern HTML 21K
17: R10 Summary of Significant Accounting Policies HTML 60K
25: R11 Related Party Transactions HTML 24K
36: R12 Preferred Stock HTML 16K
30: R13 Pending Legal Matters HTML 17K
16: R14 Lease HTML 36K
24: R15 Summary of Significant Accounting Policies HTML 104K
(Policies)
35: R16 Summary of Significant Accounting Policies HTML 47K
(Tables)
29: R17 Related Party Transactions (Tables) HTML 22K
15: R18 Lease (Tables) HTML 37K
26: R19 Going Concern (Details Narrative) HTML 24K
40: R20 Summary of Significant Accounting Policies HTML 20K
(Details)
28: R21 Summary of Significant Accounting Policies HTML 32K
(Schedule of Basic and Diluted LPS) (Details)
19: R22 Summary of Significant Accounting Policies HTML 22K
(Details Narrative)
21: R23 Related Party Transactions (Details) HTML 28K
39: R24 Related Party Transactions (Details Narrative) HTML 29K
27: R25 Preferred Stock (Details Narrative) HTML 18K
18: R26 Lease (Schedule of Components of Lease Expense and HTML 30K
Other Lease Information) (Details)
20: R27 Leases (Schedule of Future Minimum Lease HTML 26K
Commitments) (Details)
12: XML IDEA XML File -- Filing Summary XML 66K
41: EXCEL IDEA Workbook of Financial Reports XLSX 35K
6: EX-101.INS XBRL Instance -- mdxl-20190930 XML 515K
8: EX-101.CAL XBRL Calculations -- mdxl-20190930_cal XML 87K
9: EX-101.DEF XBRL Definitions -- mdxl-20190930_def XML 102K
10: EX-101.LAB XBRL Labels -- mdxl-20190930_lab XML 370K
11: EX-101.PRE XBRL Presentations -- mdxl-20190930_pre XML 276K
7: EX-101.SCH XBRL Schema -- mdxl-20190930 XSD 65K
32: ZIP XBRL Zipped Folder -- 0001553350-19-001178-xbrl Zip 53K
| Certification |
EXHIBIT 32.2
CERTIFICATION
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report of MediXall Group, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy S. Hart, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|
|
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 14, 2019 | /s/ Timothy S. Hart |
| |
| Chief Financial Officer |
| (Principal Financial Officer) |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/14/19 | None on these Dates | ||
| For Period end: | 9/30/19 | |||
| List all Filings | ||||